1. Short title This Act may be cited as the Making Objective Drug Evidence Revisions for New Labeling Act or the MODERN Labeling Act . 2. Process to update labeling for drugs with outdated labeling Chapter V of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 351 et seq.) is amended by inserting after section 503C the following: 503D. Process to update labeling for drugs with outdated labeling (a) Definitions For purposes of this section: (1) The term covered drug means a drug approved under section 505(c)— (A) for which all patents and exclusivity periods under this chapter have expired; (B) for which the approval of the label has been withdrawn; and (C) whose labeling potentially should be modified because— (i) some aspects of the labeling of the drug may be outdated according to evidence that, since the date on which the drug was so approved, has become available regarding the conditions of use reflected in the approved labeling; (ii) there is a relevant accepted use in clinical practice that is not reflected in the approved labeling